EDN1 and COVID-19: The proposed treatment does not significantly affect the concentration of endothelin-1, but a decrease in procalcitonin associated with additional antibacterial drugs was observed, especially in severe COVID-19, in addition to reduced D-dimers and procalcitonin values in all patients.